Program Director/Principal Investigator (Last, First, Middle):
BIOGRAPHICAL SKETCH
Provide the following information for the Senior/key personnel and other significant contributors in the order listed on Form Page 2.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME
POSITION TITLE
Thèrése Bocklage, M.D.
Professor, UNM School of Medicine Department of
Pathology, Director of UNM Human Tissue
Repository
eRA COMMONS USER NAME (credential, e.g., agency login)
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and
residency training if applicable.)
DEGREE
INSTITUTION AND LOCATION
MM/YY
FIELD OF STUDY
(if applicable)
Boston College
B.S.
05/82
Medical College of Toledo
University of Vermont Medical College
M.D.
05/86
6/91
University of New Mexico School of Medicine
7/92
Baylor College of Medicine, Houston Texas
7/95
Biology, A&S Honors
Program
Medical Degree
AP/CP Residency
Surgical Pathology
Fellowship
Cytopathology
Fellowship
A. Personal Statement
I am a practicing clinician educator with collaboration in translational research utilizing my skills as a
surgical pathologist and cytopathologist. The majority of my time is spent in direct patient care in surgical
pathology and cytopathology. I also participate actively in the education of pathology residents and the
surgical pathology and cytopathology fellows at our instititution. I direct the UNM Human Tissue
Repository, and in that role, I work with the NCI OBBR in optimizing human biospecimen quality through a
competitive contract awarded August, 2010. My clinical-research interests comprise tumors of the soft
tissues and bone, breast tumors, and tumors of the head and neck.
B. Positions and Honors
EMPLOYMENT:
2007-present: Professor, Department of Pathology, University of New Mexico School of Medicine
2001-2007: Associate Professor, Department of Pathology, University of New Mexico School of Medicine
1995-2001: Assistant Professor, Department of Pathology, University of New Mexico School of Medicine
1992-1994: Instructor I-III, Department of Pathology, University of New Mexico School of Medicine
POSITIONS:
2008-Current: Director, University of New Mexico SOM Human Tissue Repository
2007-Current: Director, UNM SOM Department of Pathology Cytopathology Fellowship
2006-Current: Institutional Pathology, Children’s Oncology Group (COG)
1997-2006: Director, UNM Dept. of Pathology Residency Program
MEMBERSHIPS:
Fellow, College of American Pathologists (CAP)
Fellow, American Society of Clinical Pathologists (ASCP)
Member, USCAP Soft Tissue Tumor Society
HONORS:
PHS 398/2590 (Rev. 06/09)
1|Page
Program Director/Principal Investigator (Last, First, Middle):
2004: UNM School of Medicine Excellence in Teaching Award at the Resident Education Level for
Academic Year 2003-2004
2003: Dean’s Award of Distinction for Outstanding Faculty Performance, UNM School of Medicine
Academic Year 2001-2002
2001: Dean’s Award of Distinction for Outstanding Faculty Performance, UNM School of Medicine
Academic Year 1999-2000
2000: Dean’s Award of Distinction for Outstanding Faculty Performance, UNM, School of Medicine
Academic Year 1998-1999
1999: UNM School of Medicine Excellence in Teaching Award at the Resident Education Level for
Academic Year 1997-1998
1998: Dean’s Award of Distinction for Outstanding Faculty Performance, UNM, School of Medicine,
Academic Year 1996-1997
C. Selected Peer-reviewed Publications (selected from 40 peer reviewed publications)
1. Sayar H, Bunning JT, Bocklage TJ, Lee S-J, Libby E, Rabinowitz, I. Tumor MET expression may not
predict the risk of venous thromboembolism in cancer patients. Oncology Research 19:93-97, 2010.
2. Krier K, Henderson JB, Bocklage T, Rajput A. Duodenal pseudomelanosis. Surgery 2010 Oct 21
[Epub ahead of print]
3. Smith M, Hagerty KA, Skipper B, Bocklage T. Chronic endometritis: combined histopathologic and
clinical review of cases from 2002-2007. Int J Gynecol Pathol 2010 29(1): 44-50. Review.
4. Arias-Pulido H, Smith HO, Joste NE, Bocklage T, Qualls CR, Chavez A, Prossnitz ER, Verschraegen
CF. Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low
malignant potential tumors. Gynecologic Oncology 2009 114(3):480-5.
5. Mourant JR, Powers TM, Bocklage TJ, Greene HM, Dorin MH, Waxman AG, Zsemlye MM, Smith HO.
In vivo light scattering for the detection of cancerous and precancerous lesions of the cervix. Appl
Opt. 2009 Apr 1;48(10):D26-35.
6. Davis LM, Harris C, Tang L, Doherty P, Hraber P, Sakai Y, Bocklage T, Doeden K, Hall B, Alsobrook
J, Rabinowitz I, Williams TM, Hozier J. Amplification patterns of three genomic regions predict distant
recurrence in breast carcinoma. J Molecular Diagnostics 2007 9(3):327-36.
7. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH.
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.
British J Cancer 2007 96(8):1278-83.
8. Mourant JR, Bocklage TJ, Powers TM, Greene HM, Bullock KL, Marr-Lyon LR, Dorin MH, Waxman
AG, Zsemlye MM, Smith HO. In vivo light scattering measurements for detection of precancerous
conditions of the cervix. Gynecologic Oncology 2007 105(2): 439-45.
9. Grimes JS, Bocklage TJ, Pitcher JD. Collagen and biphasic calcium phosphate bone graft in large
osseous defects. Orthopedics 2006 Feb:29(2):145-8.
10. Rosen SA, Bocklage T, Clericuzio CL. Mucocutaneous squamous papilloma with reactive lymphoid
hyperplasia in two patients with focal dermal hypoplasia. Pediatric Developmental Pathology 2005
8(2): 250-2.
11. Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons
TA, Gilliland FD, Belinsky SA. Multiplicity of abnormal promoter methylation in lung adenocarcinomas
from smokers and never smokers. International Journal Cancer 2005 114(3): 400-5.
12. Petitt M, Doeden K, Harris A, Bocklage T. Cutaneous extrarenal rhabdoid tumor with myogenic
differentiation. J Cutaneous Pathology 2005 32(10): 690-5.
13. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD,
Stidley CA, Picchi MA. Gene promoter methylation in plasma and sputum increases with lung cancer
risk. Clinical Cancer Research 2005 11(18): 6505-11.
PHS 398/2590 (Rev. 06/09)
2|Page
Program Director/Principal Investigator (Last, First, Middle):
14. Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard C, Barbash R, Willey SC,
Harlan LC. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a
population based analysis. Cancer 2005 104(9):1840-8.
15. Rund CR, Bocklage T. Pathologic quiz case: lytic femoral lesion and renal cysts in a 66-year-old man.
Occult follicular carcinoma of the thyroid. Arch Pathol Lab Med. 2004 128(3):359-60.
16. Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.
Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in
lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Cancer Research 2003 15(16):4842-8.
17. Bocklage T, Leslie K, Yousem S, Colby T. Extracutaneous angiosarcomas metastatic to the lungs:
clinical and pathologic features of twenty-one cases. Mod Pathol 2001 14(12):1216-25.
D. Research Support
1) Project Title: S09-148 Biospecimen Contributing Institutions for Research Studies in Cancer Tissue
Pre-Analytical Variables.
Role: principal investigator- Direct the project at UNM contributing ~2000 highly annotated human
blood and tissue specimen sets to the national NCI biobank.
Principal investigator: Thèrése Bocklage, M.D.
Percent effort: 15%
Funding Organization: National Cancer Institute (NCI)
Starting and stopping dates: August 2010- July 2015
Amount awarded for the period listed (direct and indirect costs): $3,829,000
2) Project Title: P30CA11800-06
Role: collaborator
Principal investigator: Cheryl L. Willman, M.D.
Percent effort: 15%
Funding Organization: National Institutes of Health (NIH)
Starting and stopping dates: October 2010-September 2015
Amount awarded for the period listed (direct and indirect costs): ~$11,000,000
3) Project Title: Clinical Translational Science Center for the University of New Mexico School of
Medicine
Role: collaborator
Principal investigator: Richard Larson, M.D., Ph.D.
Percent effort: 5%
Funding Organization: National Institutes of Health (NIH)
Starting and stopping dates: January 2011- December 2016
Amount awarded for the period listed (direct and indirect costs): ~$15,000,000
4) Project Title: P50 Subaward: Understanding and Preventing Breast Cancer Disparities in
Latinas
Role: collaborator
Principal investigator: Linda Cook, Ph.D.
Percent Effort: 5% year one, 3% years 2-5
Funding Organization: National Institutes of Health (NIH)
Starting and stopping dates: December, 2010-November 2005.
Amount awarded for the period listed (direct and indirect costs): ~ $3,000,000
PHS 398/2590 (Rev. 06/09)
3|Page